Saturday 31 October 2026
Export CTRE’s income statement to Excel — free account
CareTrust REIT, Inc.
CTRE Real Estate Reit Healthcare Facilities
CareTrust REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $476.4 million, up 60.8% from fiscal 2024. In the quarter to June 2026, revenue grew 43.5%, EPS grew 5.56%, free cash flow grew 89.0% and total debt rose 4.30%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
36.39
0.13
+0.36%
Follow CTRE
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
23.18 | 34.24 | 45.61 | 0.00 | 30.85 | 26.09 | 41.26 | 25.64 | 47.03 | 29.96 |
Piotroski F-Score |
6 | 6 | 6 | 2 | 4 | 7 | 5 | 8 | 4 | 6 |
P/S ratio |
15.46 | 14.13 | 10.87 | 9.23 | 11.40 | 11.84 | 11.75 | 9.34 | 9.25 | 8.18 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 13.21 | 0.00 | 15.71 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
60.88 | 55.68 | 55.50 | 53.68 | 56.93 | 56.53 | 61.68 | 54.34 | 56.25 | 57.39 |
P/B ratio |
1.82 | 1.44 | 1.67 | 2.13 | 2.39 | 2.31 | 2.07 | 1.91 | 2.07 | 1.89 |
Price to Tangible BV |
1.82 | 1.44 | 1.67 | 2.13 | 2.39 | 2.31 | 2.07 | 1.91 | 2.07 | 1.89 |
EV/Sales |
16.92 | 14.75 | 12.26 | 12.84 | 14.79 | 14.79 | 15.02 | 12.22 | 13.40 | 12.40 |
EV/EBITDA |
19.25 | 16.90 | 13.79 | 14.43 | 17.35 | 16.17 | 16.54 | 14.18 | 19.56 | 14.71 |
EV/Operating CF |
20.46 | 17.89 | 17.25 | 17.43 | 18.14 | 18.10 | 19.44 | 19.31 | 20.07 | 20.15 |
EV/FCF |
(7.33) | (7.52) | (28.46) | 18.36 | (67.98) | 19.62 | (12.18) | (72.96) | (8.53) | (6.02) |
Quick Ratio |
1.73 | 3.82 | 8.67 | 0.56 | 0.88 | 1.06 | 1.53 | 3.02 | 0.70 | 1.10 |
Current Ratio |
1.73 | 3.82 | 8.67 | 0.56 | 0.88 | 1.06 | 1.53 | 3.02 | 0.70 | 1.10 |
Net Debt/EBITDA |
1.66 | 0.71 | 1.56 | 4.05 | 3.98 | 3.23 | 3.60 | 3.35 | 6.06 | 5.01 |
Debt/Assets |
17.37% | 11.55% | 28.57% | 44.39% | 41.04% | 36.29% | 36.52% | 37.91% | 47.17% | 48.60% |
Debt/Equity |
0.22 | 0.14 | 0.42 | 0.85 | 0.74 | 0.60 | 0.60 | 0.64 | 0.94 | 0.99 |
Asset Turnover |
0.11 | 0.11 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.13 | 0.13 | 0.13 |
Operating CF/Net income |
1.23 | 1.96 | 2.90 | (18.17) | 2.19 | 1.80 | 2.74 | 1.72 | 3.48 | 2.20 |
Capex/Depreciation |
(14.57) | (13.10) | (4.25) | (0.13) | (2.91) | (0.19) | (5.65) | (2.44) | (6.81) | (7.83) |
Interest Coverage |
7.23 | 6.46 | 3.31 | 3.87 | 4.04 | 4.42 | 3.22 | 3.01 | 1.96 | 2.29 |
| 9.20% | 5.76% | 4.70% | (0.90%) | 7.81% | 8.78% | 5.43% | 8.50% | 4.87% | 8.21% | |
| 7.45% | 4.51% | 2.88% | (0.49%) | 4.55% | 5.35% | 3.28% | 4.68% | 2.42% | 3.67% | |
ROIC |
4.17% | 3.95% | 4.91% | 4.67% | 3.81% | 4.54% | 3.87% | 4.29% | 2.58% | 3.67% |
Return on Tangible Assets |
8.42% | 5.22% | 2.92% | (0.56%) | 4.50% | 5.58% | 3.24% | 4.64% | 2.22% | 3.28% |
Average Days of Receivables |
7.94 | 1.45 | 0.66 | 0.77 | 4.59 | 3.73 | 5.74 | 26.48 | 14.42 | 20.56 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
11.01% | 9.76% | 10.01% | 10.28% | 13.97% | 9.14% | 9.28% | 8.00% | 8.36% | 8.88% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(0.12) | (0.07) | (0.16) | (0.42) | (0.32) | (0.27) | (0.30) | (0.32) | (0.47) | (0.54) |
Graham Number |
26.39 | 18.28 | 12.15 | 0.00 | 12.60 | 13.55 | 10.59 | 12.52 | 8.14 | 9.63 |
Earnings Yield |
4.31% | 2.92% | 2.19% | (0.43%) | 3.24% | 3.83% | 2.42% | 3.90% | 2.13% | 3.34% |
Free Cash Flow Yield |
(14.93%) | (13.87%) | (3.96%) | 7.57% | (1.91%) | 6.37% | (10.49%) | (1.79%) | (16.98%) | (25.18%) |
Revenue per Share |
2.34 | 1.91 | 2.06 | 2.03 | 2.00 | 1.87 | 1.76 | 1.98 | 1.83 | 1.87 |
Operating CF per Share |
1.93 | 1.58 | 1.46 | 1.49 | 1.63 | 1.53 | 1.36 | 1.25 | 1.22 | 1.15 |
Capex per Share |
(7.33) | (5.33) | (2.35) | (0.08) | (2.07) | (0.12) | (3.52) | (1.58) | (4.10) | (5.00) |
Free Cash Flow per Share |
(5.40) | (3.75) | (0.89) | 1.42 | (0.44) | 1.41 | (2.16) | (0.33) | (2.88) | (3.85) |
Cash per Share |
0.97 | 1.38 | 2.78 | 0.14 | 0.21 | 0.20 | 0.22 | 0.46 | 0.10 | 0.13 |
Shareholders Equity per Share |
19.84 | 18.81 | 13.39 | 8.78 | 9.54 | 9.60 | 9.96 | 9.68 | 8.19 | 8.07 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
19.84 | 18.81 | 13.39 | 8.78 | 9.54 | 9.60 | 9.96 | 9.68 | 8.19 | 8.07 |
Free Cash Flow |
(1,099.21) | (580.97) | (93.78) | 137.12 | (41.86) | 134.44 | (201.45) | (26.29) | (208.87) | (215.55) |
Working Capital |
87.97 | 158.68 | 260.85 | (10.77) | (3.09) | 1.17 | 7.94 | 32.21 | (5.25) | 1.26 |
Capital Expenditures |
(1,493.24) | (825.22) | (248.55) | (7.29) | (198.73) | (11.30) | (327.75) | (125.65) | (297.67) | (279.99) |
Net Current Asset Value |
(899.21) | (310.88) | (371.28) | (757.81) | (702.78) | (568.67) | (568.37) | (475.34) | (578.21) | (459.53) |
EV/EBIT |
25.50 | 22.34 | 19.75 | 21.65 | 29.72 | 25.23 | 27.13 | 22.91 | 37.58 | 24.73 |
Capex to Sales |
3.13 | 2.79 | 1.14 | 0.04 | 1.03 | 0.06 | 2.01 | 0.80 | 2.24 | 2.67 |
Price to Operating Income |
23.29 | 21.40 | 17.52 | 15.58 | 22.90 | 20.19 | 21.23 | 17.50 | 25.94 | 16.31 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Cash ROIC |
(21.41%) | (16.50%) | (4.06%) | 8.67% | (2.60%) | 9.09% | (13.41%) | (2.03%) | (18.00%) | (23.70%) |
Accounts Receivable Turnover |
82.55 | 377.68 | 537.04 | 138.41 | 90.71 | 81.17 | 23.41 | 18.86 | 23.85 | 25.41 |
Accounts Payable Turnover |
0.10 | 0.17 | 0.21 | 0.17 | 0.16 | 0.16 | 0.20 | 0.71 | 0.69 | 0.73 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
5,013.84 | 2,622.62 | 2,010.87 | 2,052.02 | 2,594.83 | 2,518.96 | 1,791.71 | 488.76 | 619.83 | 564.62 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
5.77 | 0.78 | 0.41 | 1.42 | 2.12 | 2.20 | 6.98 | 8.32 | 5.58 | 4.12 |
Average Payables |
88.38 | 45.16 | 29.18 | 24.88 | 22.49 | 17.27 | 15.46 | 16.69 | 14.78 | 10.70 |
Average Assets |
4,292.73 | 2,760.93 | 1,852.81 | 1,630.81 | 1,572.20 | 1,511.21 | 1,405.31 | 1,238.37 | 1,055.17 | 799.26 |
Average Common Equity |
3,475.98 | 2,164.93 | 1,134.05 | 882.57 | 914.95 | 920.87 | 847.92 | 681.43 | 523.52 | 357.36 |
Columns are period end dates